订阅小程序
旧版功能

A Phase II Study of Zandelisib in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: ME-401-K02 Study.

Wataru Munakata,Takahiro Kumode,Hideki Goto,Noriko Fukuhara,Tatsu Shimoyama,Masahiro Takeuchi,Toshiro Kawakita,Kohmei Kubo,Masashi Sawa,Toshiki Uchida,Yuko Mishima,Michiko Ichii, Miyoko Hanaya,Asuka Matsumoto, Masaaki Kuriki,Toshihiro Seike,Koji Izutsu,Kenichi Ishizawa

BRITISH JOURNAL OF HAEMATOLOGY（2025）

引用 0|浏览2
关键词
follicular lymphoma,indolent non-Hodgkin lymphoma,marginal zone lymphoma,PI3K delta inhibitor,zandelisib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要